Healthcare Giants Report Mixed Q3 2025 Results: CVS Health Soars While Teladoc Health Stumbles
Table of Contents
A turbulent quarter for the healthcare sector saw CVS Health exceed expectations despite meaningful losses in its care delivery business, while Teladoc Health experienced a revenue decline, signaling ongoing challenges in the telehealth market. These contrasting performances on October 29, 2025, highlight the evolving landscape of healthcare and the varying success of different business models. Investors are closely watching these trends as they shape the future of healthcare access and delivery.
CVS Health reported a robust 7.8% increase in revenue for the third quarter of 2025, leading to revised and increased earnings estimates for the year. However, this positive outlook is tempered by a considerable $6 billion charge related to its struggling care delivery business. The company absorbed the hit, demonstrating its ability to offset underperforming segments with strength in other areas.
“The overall financial performance demonstrates the resilience of CVS Health’s diversified business model,” stated one analyst.the charge reflects the difficulties encountered in scaling and integrating recent acquisitions within the care delivery sector, prompting a reassessment of strategy.
OnMed Set to Go Public Through SPAC Merger
In a separate progress, health kiosk vendor OnMed announced a merger with special purpose acquisition company Berto, paving the way for an initial public offering (IPO).This move suggests growing investor confidence in the potential of convenient, technology-driven healthcare solutions.The merger is expected to provide OnMed with the capital needed to expand its network of kiosks and enhance its service offerings.
Teladoc Health Faces Continued Headwinds
Teladoc Health,a leading provider of telehealth services,reported a 2% decrease in revenue for the third quarter of 2025. the company’s Better Help online mental health segment continued its downward trend, experiencing another quarterly decline. This suggests increasing competition and evolving consumer preferences within the mental health space.
According to a company release, Teladoc Health is focused on streamlining operations and improving profitability. The company is exploring new strategies to revitalize growth in its core telehealth business and address the challenges facing Better Help.The results underscore the difficulties in sustaining rapid growth in the increasingly crowded telehealth market.
The diverging fortunes of CVS Health and Teladoc Health in Q3 2025 serve as a stark reminder of the complexities and competitive pressures within the healthcare industry, and the need for adaptability and strategic foresight to thrive.
Expanded news Report:
Why: The healthcare sector experienced a mixed quarter due to varying business strategies and market conditions. CVS Health’s diversified model allowed it to absorb losses in care delivery, while Teladoc Health struggled with increased competition and declining demand in specific segments. OnMed’s planned IPO reflects investor interest in innovative healthcare delivery methods.
Who: Key players include CVS Health, Teladoc Health, OnMed, and Berto (the SPAC merging with OnMed). Analysts and investors are also significant stakeholders observing these trends.
What: CVS Health reported a 7.8% revenue increase despite a $6 billion charge. Teladoc Health experienced a 2% revenue decrease, especially in its Better Help segment. OnMed is merging with Berto to become a publicly traded company.
How did it end?:
